← Back to Search

Peer Navigation + mHealth for HIV/AIDS, STIs, and Hepatitis C Testing

N/A

Recruiting

Led By Scott D. Rhodes, Ph.D, MPH

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Report being assigned male sex at birth and having had sex with at least 1 man in the past 12 months

Be ≥18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a new intervention to increase HIV, STI, and HCV testing among GBMSM and transgender women in rural Appalachia.

Who is the study for?

This trial is for adults over 18 living in rural Appalachian counties, assigned male at birth and have had sex with a man in the past year. They must consent to participate. It's aimed at racially/ethnically diverse gay, bisexual men, and transgender women.

What is being tested?

The study tests a combined intervention of peer navigation support and mobile health (mHealth) technology to improve HIV, STI, and HCV prevention and care services among participants compared to those receiving delayed intervention.

What are the potential side effects?

Since this trial involves non-medical interventions like peer support and mobile health technologies rather than drugs or medical procedures, traditional side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was assigned male at birth and have had sex with a man in the last year.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline). for reporting.